ClearPoint Neuro Announces FDA Clearance and First-in-Human Cases
$ 7.50 · 4.9 (622) · In stock
Clinical Validation of the Brain Model Published Online in the Journal NeuroImage ClearPoint Maestro Brain Model ClearPoint Maestro Brain Model ClearPoint Neuro Maestro Brain Model Comparative Reproducibility Error Results Reproducibility error of Maestro (green), FreeSurfer 7.2 (blue) and manual segmentation (red) for common brain structures (left), and average over all structures (right). Bars represent range of measured relative volume difference. SOLANA BEACH, Calif., Feb. 21, 2024 (GLOBE NE
Clinical Validation of the Brain Model Published Online in the Journal NeuroImage ClearPoint Maestro Brain Model ClearPoint Maestro Brain Model ClearPoint
FDA Clears DyAnsys Neurostimulation Device Primary Relief to Treat Post-Cardiac Surgery Pain
SNN
Celebrating 10 years of FDA clearance
ClearPoint Neuro, Inc. on LinkedIn: ClearPoint Neuro Announces FDA Clearance for ClearPoint Maestro™ Brain…
Global Neuronavigation Systems Market to Grow at a CAGR of 6.1% During the Period 2022-2027
Tarveda Therapeutics, Inc. - Drug pipelines, Patents, Clinical
SNN
Our History
Regulation Archives - NS Medical Devices
Michael Bigger on X: Day 1 $CLPT / X
SNN
SNN